4Christmann U, Buechner-Maxwell VA, Witonsky, SG. et al. Role of lung surfactant in respiratory disease: Current knowledge in large animal medlcine[J]. J Vet Intern Med,2009 ,23(2): 227-242.
6Gibson PG. Using fractional exhaled nitric oxide to guide asthma therapy: Design and methodological issues for asthma TReatment algorithm studies[J]. Clin Exp Allergy,2009 ,39(4): 478-490.
7Malerba M,Mennuni L,Piepoli T,et al. Andolastacts at different cellular levels to inhibit immunoglobulin E synthesis[J]. Int J Immunopathol Pharmacol,2009,22(1) : 85-94.
8Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, populatiorrbased survey[J]. Am J Respir Crit Care Med, 2007, 176(8): 753-760.
9Zheng JP, Kang J, Huang SG, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study) : a random- ised placebo-controlled study[J]. Lancet, 2008, 371(9629) : 2013 2018.
10Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseEJ~. N Engl J Med, 2007, 356(8) :775-789.
